Skip to content
Sora Lifesciences
Market Intelligence

Estimating procedure volumes when published data is scarce

Most MedTech markets don't have clean, public procedure data. Here's how triangulation across registries, guidelines, and primary research produces reliable estimates.

Apr 3, 2026

Reliable market sizing rarely comes from a single source. In MedTech, procedure volumes must usually be reconstructed from epidemiology, care-pathway logic, and primary validation with clinicians.

We walk through a triangulated approach — combining top-down modelling with bottom-up, facility-level estimation — and how KOL interviews sharpen the assumptions that matter most.

Get in touch

Want to talk this through?

Tell us what decision you're facing. We'll turn it into a clear, evidence-backed answer.

© 2026 Sora Life Sciences. All rights reserved.